COVID‑19–sensitive tumour response - 2-year assessment - of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland
Favorite
Share
More Options
Fullscreen
This document is user-generated content (UGC). WPS Office is not responsible for its accuracy or copyright. If you believe this content violates your rights, please use the button.
